Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.